Selank, cytokines and inflammation genes: what the mouse studies found

Published August 28, 2026 · Artemis Labs

Selank is built from tuftsin, a natural fragment of an antibody molecule that acts on immune cells, so the immune side of its research is not a sideline — it is the compound’s origin. Studies in mouse spleen report that a single injection changes the expression of dozens of inflammation-related genes within hours, and a rat study reports altered cytokine levels under social stress. One finding in that series deserves more attention than it gets: a short two-residue fragment of Selank, Gly-Pro, produced largely the same gene-expression profile as the whole peptide. If a fragment does most of what the molecule does, the interesting unit may not be the molecule.

Key findings

• In mouse spleen, six and twenty-four hours after a single injection: “We found significant changes in the expression of 34 genes involved in inflammation processes,” with the Bcl6 gene highlighted as responding to each peptide tested (PMID 21609736).
• Following that up on a finer timescale: “a significant 3-fold decrease in the C3 mRNA level just 30 min after Selank injection and similar alteration this gene mRNA level after Gly-Pro administration” (PMID 24291245).
• The fragment result, verbatim: “in most cases, there was a coincidence in the expression profiles of the studied genes after Selank and its fragment.”
• In rats under a social-confrontation stress model, cytokine levels were measured with results the authors read as indicating “the presence of stress-protective activity” (PMID 32621722).

Why an anxiety peptide is studied in the spleen

Tuftsin — Thr-Lys-Pro-Arg, the first four residues of Selank — is released from the heavy chain of an antibody and stimulates immune cells. It is an immune molecule by origin, not a brain molecule.

Selank is that fragment with a stabilizing tail. So when Russian researchers began studying what it does, looking at immune tissue was the obvious first move, and the spleen — dense with immune cells — is the standard place to look.

The framing that emerged from this work is neuroimmune: the idea that stress, inflammation and behavior are one connected system, not three separate ones. Cytokines, the signaling proteins immune cells use, also act on the brain. A molecule that touches both sides is interesting to study for that reason alone, regardless of whether it turns out to be useful for anything.

What the gene-expression studies measured

The 2011 study gave mice a single injection of Selank or one of its fragments and measured 84 genes involved in inflammation — chemokines, cytokines and their receptors — in the spleen at six and twenty-four hours. Thirty-four genes changed significantly. The authors singled out Bcl6, a gene central to the formation and development of the immune system, because it responded to each of the peptides tested and its target and corepressor genes moved with it.

The 2014 follow-up narrowed to four genes — C3, Casp1, Il2rg and Xcr1 — and looked much earlier, from thirty minutes. The clearest result was a threefold drop in C3 messenger RNA at thirty minutes. Casp1 showed what the authors called a wave-like pattern rather than a single shift, which is a useful reminder that “gene expression changed” can mean several different shapes over time.

The 2021 rat study moved from genes to the proteins themselves, measuring cytokines in animals subjected to a social stress model: pairs of male rats housed either side of a partition that was removed daily, producing confrontations. The authors read their results as showing stress-protective activity.

The fragment result, and the question it raises

Across both mouse studies, Selank was tested alongside its own short fragments, and the fragments did much the same thing. In the 2014 paper the two-residue Gly-Pro produced a C3 decrease similar to Selank’s, an almost equal reduction in Xcr1 at ninety minutes, and — in the authors’ own summary — coincident expression profiles in most of the genes studied.

This is the sort of result that changes how a compound should be described. If a two-residue fragment reproduces most of the seven-residue peptide’s effect on these genes, then the effect may belong to the fragment rather than to Selank as a designed molecule. The authors themselves point that way, noting the finding “might indicate an active contribution” of the fragment.

It also connects to a broader observation in this literature: Pro-Gly-Pro, the stabilizing tail Selank shares with Semax and other Russian glyprolines, is itself biologically active and has its own published studies. The family may share more of its effects than the individual compound names suggest.

We publish this because it is the strongest published reason for caution about attributing the immune findings to Selank specifically, and because no competitor page mentions it.

What the research does not show

None of this is human immune research. The gene-expression work is in mouse spleen; the cytokine work is in rats. The one human study touching immune measures reported in vitro suppression of IL-6 gene expression in cells from patients with depression, not a clinical immune outcome.

Changes in messenger RNA are not changes in protein, and neither is a demonstrated effect on immune function. These studies measure signals, several steps upstream of anything an immune system does.

Nothing here shows a benefit for any condition. The studies are descriptive: a peptide was given, gene expression moved, the authors reported the pattern.

And the fragment finding means the attribution itself is uncertain. Where a two-residue fragment reproduces the profile, “Selank changes inflammation gene expression” may be a less accurate description than “a fragment present in Selank does.”

Frequently asked questions

Does Selank affect the immune system?

In mice, single injections changed the expression of dozens of inflammation-related genes in the spleen. Whether that amounts to an effect on immune function has not been tested.

What are cytokines?

Signaling proteins immune cells use to communicate — IL-6, TNF-α and others. They also act on the brain, which is why they appear in stress research as well as immunology.

Why does tuftsin matter here?

Because it is Selank’s parent and an immune peptide in its own right. Our identity page sets out how the two molecules relate and how they differ.

Is the immune research stronger than the anxiety research?

It is more mechanistic and entirely preclinical. The anxiety research includes human trials, though with the limitations set out on our human trials page.

References

1. Kolomin T, Shadrina M, Andreeva L, Slominsky P, Limborska S, Myasoedov N. Regul Pept. 2011. PMID 21609736. DOI 10.1016/j.regpep.2011.05.001.
2. Kolomin T, Morozova M, Volkova A, Shadrina M, Andreeva L, Slominsky P, et al. Mol Immunol. 2014. PMID 24291245. DOI 10.1016/j.molimm.2013.11.002.
3. Leonidovna YA, Aleksandrovna SM, Aleksandrovna TA, Aleksandrovna BO, Fedorovich MN, Aleksandrovna AL. Curr Rev Clin Exp Pharmacol. 2021. PMID 32621722.
4. Uchakina ON, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2008. PMID 18577961.
5. Czabak-Garbacz R, Cygan B, Wolański L, Kozlovsky I. Pharmacol Rep. 2006. PMID 16963804.

Methodology: quotations are verbatim from the published abstracts of the cited studies, retrieved through NCBI E-utilities on August 28, 2026. Every animal result names its species and tissue.

All compounds sold by Artemis Labs are for laboratory research use only. Nothing on this page is medical advice, and no statement has been evaluated by the FDA.